Proliferation index is related to patient age in glioblastoma

Neurology

Volumn 56, Issue 9, 2001, Pages 1216-1218

  McKeever, Paul E ^a,c   Junck, L ^a   Strawderman, M S ^b   Blaivas, M ^a   Tkaczyk, A ^a   Cates, M A ^a   Yan, M ^a   Li, L ^b  

^a Cancer Registry ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; GLIOBLASTOMA; HUMAN; IMMUNOCOMPETENCE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

EID: 0035826785     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.9.1216     Document Type: Article

References (10)

1. Glioma
2. MIB-1 proliferation index predicts survival among patients with grade II astrocytomas
3. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas
4. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: Correlation with MIB1 expression and patient survival
5. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: A study of 101 cases
6. Age-related chemosensitivity of stem cells from human malignant brain tumours
7. Age influences chemotherapy response in astrocytomas
8. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme
9. Evaluating glioma therapies: Modeling treatments and predicting outcomes
10. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases